Severe conditions like pneumonia and trouble breathing can occur in 65+ who get infected with RSV. Nearly 200,000 elderly people are hospitalized with the virus every year.
Young children are also at high risk for serious complications.
Underlying heart or lung conditions, a weakened immune system, COPD, or asthma can worsen the outcome for those who get infected with RSV.
There’s no vaccine for RSV—yet. You can help change that. Please consider participating in RSV vaccine clinical trials. Your participation could protect you and those you love against RSV, now and in the future.
Tell us a little bit about yourself
Answer some questions about your health
We will connect you to available studies in your area
For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.
AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.